General Injectables and Vaccines, Inc. – Trademark Portfolio

Entity Type: 03

General Injectables and Vaccines, Inc. has 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Filings span 4 Nice Classification classes, led by Class 42 (Computer & Scientific) and Class 5 (Pharmaceuticals). This trademark owner is based in Bastian, VA.

P.O. Box 9

Highway 21 & 52

Bastian, VA 24314

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

General Injectables and Vaccines, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (5 filings)

Scientific and technological services; industrial analysis and research services

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does General Injectables and Vaccines, Inc. have?

General Injectables and Vaccines, Inc. has 11 U.S. trademarks filed with the USPTO.

What trademark classes does General Injectables and Vaccines, Inc. file in?

General Injectables and Vaccines, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 10 (Medical Apparatus). Class 42 covers scientific and technological services; industrial analysis and research services.

What is General Injectables and Vaccines, Inc.'s trademark registration success rate?

General Injectables and Vaccines, Inc. has a 0% trademark registration rate, with 0 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.